- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04203277
Improving Vaccinations for Young Children (IVY) (IVY)
Study Overview
Detailed Description
The proposed work seeks to improve Combination 10 vaccination rates for Tennessee children at 2 years of age through the development and implementation of a new program, Improving Vaccination for Young Children (IVY). Through a collaboration with the Cumberland Pediatrics Foundation (CPF), a non-profit company focused on improving health care services for Tennessee's children, investigators plan to adapt and disseminate existing CoVER educational materials for community pediatric providers and clinical staff, and develop and implement targeted quality improvement (QI) initiatives.
A.3. Specific Objectives:
- Design interactive web-based modules individualized for two groups (pediatric providers and pediatric clinical staff) to educate on key vaccine topics. Modules will include information related to 1) diseases vaccines are targeting, including influenza 2) vaccine contraindications, common misconceptions, and vaccine safety, 3) communication techniques, 4) vaccine schedules and catch up rules, and 5) exemptions, school requirements, and practice dismissal.
- Design an in-person QI coaching session incorporating key drivers for improved vaccination rates. The session will be developed using the 4Pillars™ Practice Transformation Program (4Pillars™) and will include introduction of 1) acute visits for vaccine catch up, 2) team-based care practices, 3) standing vaccination record review and vaccination orders, and 4) reminder/recall systems.
- Implement educational modules and QI coaching session at specific time points within the context of a stepped wedge cluster randomized trial (SW-CRT). Combination 10 [(Combo 10)] vaccine rates will be collected monthly from the Electronic Health Record (EHR) of recruited practices for eligible children turning 2 years of age. Vaccine rates will be compared between practices monthly within the SW-CRT design. Rates will also be evaluated by practice over time.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Tennessee
-
Nashville, Tennessee, United States, 37232
- Sarah E Williams
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- pediatric clinics
- serving children at minimum up to age 2
- located in Tennessee
Exclusion Criteria:
-none
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Step Wedge Randomized Group 1
Includes two pediatric practices randomized to the first step of the step-wedge randomized trial
|
a combination of practice education and quality improvement interventions
|
|
Experimental: Step Wedge Randomized Group 2
Includes two pediatric practices randomized to the second step of the step-wedge randomized trial
|
a combination of practice education and quality improvement interventions
|
|
Experimental: Step Wedge Randomized Group 3
Includes two pediatric practices randomized to the third step of the step-wedge randomized trial
|
a combination of practice education and quality improvement interventions
|
|
Experimental: Step Wedge Randomized Group 4
Includes two pediatric practices randomized to the fourth step of the step-wedge randomized trial
|
a combination of practice education and quality improvement interventions
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Combination 10 vaccination rates in 2 year old children
Time Frame: Assessing change in combination 10 vaccination rates in 2 year old children up to 12 months
|
The primary outcome is individual patient-level receipt of all vaccinations [Combo 10 (binary, yes/no)] for children turning 2 years of age in prior month.
|
Assessing change in combination 10 vaccination rates in 2 year old children up to 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Combination 3 vaccination rates in 2 year old children
Time Frame: Assessing change in combination 3 vaccination rates in 2 year old children up to 12 months
|
The primary outcome is individual patient-level receipt of all vaccinations [Combo 3 (binary, yes/no)] for children turning 2 years of age
|
Assessing change in combination 3 vaccination rates in 2 year old children up to 12 months
|
|
Additional sub analyses of combination 10 vaccination rates (excluding flu vaccine) in 2 year old children
Time Frame: Assessing change in combination 10 vaccination (excluding flu vaccine) rates in 2 year old children up to 12 months
|
We will adjust our data and analyze combo 10 vaccination rates minus influenza vaccine.
|
Assessing change in combination 10 vaccination (excluding flu vaccine) rates in 2 year old children up to 12 months
|
|
Additional sub analyses of combination 10 vaccination rates in 2 year old children adjusting for proportion of practice who complete educational training
Time Frame: Assessing how "dose" of educational training affects change in combination 10 vaccination rates in 2 year old children up to 12 months
|
We will determine proportion of the practice who completed the educational training and conduct a dose analysis.
|
Assessing how "dose" of educational training affects change in combination 10 vaccination rates in 2 year old children up to 12 months
|
|
Additional sub analyses of combination 10 vaccination rates in 2 year old children adjusting for whether practice represents a community or academic population
Time Frame: Assessing change in combination 10 vaccination rates in 2 year old children up to 12 months, adjusting for educational "dose"
|
We will adjust for the bivariate variable of community versus academic population within our analysis model.
Community practices are those that are recruited by our partner Cumberland Pediatric Foundation and academic practices are those directly affiliated with Vanderbilt.
|
Assessing change in combination 10 vaccination rates in 2 year old children up to 12 months, adjusting for educational "dose"
|
Collaborators and Investigators
Investigators
- Principal Investigator: Sarah E Williams, MD, MPH, Vanderbilt University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 190032
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vaccination Refusal
-
Boston Medical CenterMerck Sharp & Dohme LLCRecruitingVaccine Hesitancy | Vaccine RefusalUnited States
-
Johns Hopkins Bloomberg School of Public HealthMerck Sharp & Dohme LLC; Emory University; Children's Healthcare of AtlantaRecruitingVaccine Hesitancy | Vaccine RefusalUnited States
-
Emory UniversitySuspendedVaccination RefusalUnited States
-
MultiCare Health System Research InstituteMerck Sharp & Dohme LLCActive, not recruiting
-
Chinese University of Hong KongRecruitingVaccination RefusalHong Kong
-
University of YalovaActive, not recruitingChildren | Machine Learning | Vaccine Hesitancy | Vaccine RefusalTurkey (Türkiye)
-
University of IowaNational Institute on Aging (NIA)CompletedVaccination | Vaccination Hesitancy | Vaccination Promotion | Psychological AspectsUnited States
-
Istanbul University - CerrahpasaActive, not recruitingChildhood ImmunizationTurkey (Türkiye)
-
Duke UniversityUniversity of South CarolinaCompletedVaccine HesitancyUnited States
-
Hospital Israelita Albert EinsteinMinistry of Health, BrazilRecruitingVaccine Hesitancy | Vaccine RefusalBrazil
Clinical Trials on IVY
-
Engelhard Arzneimittel GmbH & Co.KGCompleted
-
Engelhard Arzneimittel GmbH & Co.KGUnknownSymptoms of Acute Bronchitis Accompanied by CoughingGermany
-
Technische Universität DresdenUnknown
-
PharmEvo Pvt LtdCompletedCough | Common ColdPakistan
-
Healthcare Homoeo Charitable SocietyUnknownRheumatoid Arthritis.India
-
University of California, San FranciscoNational Institute of Mental Health (NIMH); RTI International; AIDS Healthcare...Active, not recruitingHIV/AIDS | Substance Use | Mental Health Issue | Young Adult | Mobile HealthUnited States
-
Pontificia Universidad Catolica de ChileUC CHRISTUSCompletedUpper Resp Tract InfectionChile